Co-Authors
This is a "connection" page, showing publications co-authored by Jan Rybniker and Jakob Malin.
Connection Strength
1.661
-
Remdesivir against COVID-19 and Other Viral Diseases. Clin Microbiol Rev. 2020 12 16; 34(1).
Score: 0.908
-
Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol Med. 2021 08 09; 13(8):e14150.
Score: 0.238
-
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis. J Antimicrob Chemother. 2021 02 11; 76(3):825-827.
Score: 0.232
-
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2. EMBO Mol Med. 2021 01 11; 13(1):e13105.
Score: 0.228
-
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill. 2020 05; 25(21).
Score: 0.055